These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10504169)

  • 21. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
    Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
    Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Goal and results of the COSS study].
    Flege S; Bielack S
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant systemic therapy and the surgical management of breast cancer.
    Waljee JF; Newman LA
    Surg Clin North Am; 2007 Apr; 87(2):399-415, ix. PubMed ID: 17498534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
    Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of polychemotherapy in the management of malignant bone tumors].
    Reichardt P; Dörken B
    Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma.
    Ferrari S; Palmerini E
    Curr Opin Oncol; 2007 Jul; 19(4):341-6. PubMed ID: 17545797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Popat S; Smith IE
    J Natl Cancer Inst; 2005 Jun; 97(11):858; author reply 858-9. PubMed ID: 15928308
    [No Abstract]   [Full Text] [Related]  

  • 32. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibilities and perspectives of adjuvant chemotherapy in malignant tumors].
    Tanneberger S
    Vopr Onkol; 1989; 35(8):899-904. PubMed ID: 2800442
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: equivalent outcomes?
    Smith BL
    Ann Surg; 2013 Feb; 257(2):180-1. PubMed ID: 23291659
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoadjuvant therapy.
    Forastiere AA; Urba SG; Liggett W
    Cancer J Sci Am; 1996; 2(3):126-31. PubMed ID: 9166510
    [No Abstract]   [Full Text] [Related]  

  • 36. Brain tumors as second malignant neoplasms in patients with osteosarcoma treated with adjuvant and neoadjuvant chemotherapy: report of 2 cases.
    Longhi A; Gamberi G; Bacci G
    J Chemother; 2000 Jun; 12(3):261-2. PubMed ID: 10877524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.
    Weiss RB; DeVita VT
    Ann Intern Med; 1979 Aug; 91(2):251-60. PubMed ID: 380437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of adjuvant chemotherapy on periosteal osteosarcoma: a systematic review.
    Tsukamoto S; Righi A; Kido A; Honoki K; Tanaka Y; Fujii H; Mavrogenis AF; Tanaka Y; Errani C
    Jpn J Clin Oncol; 2022 Aug; 52(8):896-904. PubMed ID: 35485208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of adjuvant systemic chemotherapy in breast cancer in The Netherlands assumes a greater number of patients than is available].
    Gaasbeek Janzen HM; Eliel M
    Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2111. PubMed ID: 7477573
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intra- or Postoperative Chemoprophylaxis? (author's transl)].
    Senn HJ
    Langenbecks Arch Chir; 1975 Nov; 339():85-93. PubMed ID: 813077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.